Cardiovascular magnetic resonance in wet beriberi

por Essa, Essa, Velez, Michael R, Smith, Sakima, Giri, Shivraman, Raman, Subha V, Gumina, Richard J
Publicado 2011

Type of Valvular Heart Disease Requiring Surgery in the 21st Century: Mortality and Length-of-Stay Related to Surgery

por Boudoulas, Konstantinos Dean, Ravi, Yazhini, Garcia, Daniel, Saini, Uksha, Sofowora, Gbemiga G., Gumina, Richard J., Sai-Sudhakar, Chittoor B.
Publicado 2013

Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice

por De Giorgi, Marco, Enjyoji, Keiichi, Jiang, Gordon, Csizmadia, Eva, Mitsuhashi, Shuji, Gumina, Richard J., Smolenski, Ryszard T., Robson, Simon C.
Publicado 2017

Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art

por Al-abcha, Abdullah, Radwan, Yasser, Blais, Danielle, Mazzaferri, Ernest L., Boudoulas, Konstantinos Dean, Essa, Essa M., Gumina, Richard J.
Publicado 2022

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

por Evans, John P., Zeng, Cong, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

por Evans, John P., Zeng, Cong, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

The role of CD38 in ischemia reperfusion injury in cardiopulmonary bypass and thoracic transplantation: a narrative review

por Gouchoe, Doug A., Vijayakumar, Ammu, Aly, Ahmed H., Cui, Ervin Y., Essandoh, Michael, Gumina, Richard J., Black, Sylvester M., Whitson, Bryan A.
Publicado 2023

Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant

por Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant

por Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

por Zeng, Cong, Evans, John P., Faraone, Julia N., Qu, Panke, Zheng, Yi-Min, Saif, Linda, Oltz, Eugene M., Lozanski, Gerard, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Erratum for Zeng et al., “Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H”

por Zeng, Cong, Evans, John P., Faraone, Julia N., Qu, Panke, Zheng, Yi-Min, Saif, Linda, Oltz, Eugene M., Lozanski, Gerard, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3

por Faraone, Julia N., Qu, Panke, Goodarzi, Negin, Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Jones, Daniel, Gumina, Richard J., Liu, Shan-Lu
Publicado 2023

Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Yu, Lianbo, Ma, Qin, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants

por Evans, John P., Qu, Panke, Zeng, Cong, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Lozanski, Gerard, Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Mohler, Peter J., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients

por Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2021

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

por Zeng, Cong, Evans, John P., Reisinger, Sarah, Woyach, Jennifer, Liscynesky, Christina, Boghdadly, Zeinab El, Rubinstein, Mark P., Chakravarthy, Karthik, Saif, Linda, Oltz, Eugene M., Gumina, Richard J., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2021

Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants

por Qu, Panke, Xu, Kai, Faraone, Julia N., Goodarzi, Negin, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Horowitz, Jeffrey C., Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Jones, Daniel, Gumina, Richard J., Liu, Shan-Lu
Publicado 2023

Trauma-Induced Nanohydroxyapatite Deposition in Skeletal Muscle is Sufficient to Drive Heterotopic Ossification

por Moore-Lotridge, Stephanie N., Li, Qiaoli, Gibson, Breanne H. Y., Martin, Joseph T., Hawley, Gregory D., Arnold, Thomas H., Saito, Masanori, Tannouri, Sami, Schwartz, Herbert S., Gumina, Richard J., Cates, Justin M. M., Uitto, Jouni, Schoenecker, Jonathan G.
Publicado 2018

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants

por Qu, Panke, Faraone, Julia, Evans, John P., Zou, Xue, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Lozanski, Gerard, Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Mohler, Peter J., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022